Ken Schulz

Ken Schulz has over a decade of experience in the biopharmaceutical industry, currently serving as the Area Care Team Manager for Neuro Rare Disease at Genentech since June 2019. Prior roles include Director of Market Access at Dermira, Inc., and various positions at Genentech, where responsibilities encompassed leading strategies for Xolair and market planning for oral octreotide. Ken's early career began at Stanford University, where a PhD in Immunology was obtained, along with significant research on IL-6 biology in immune cells. Ken also gained valuable marketing insights as a Pipeline Marketing Intern at Genentech and participated in a Commercial Rotational Development Program. Educational qualifications include a BS in Biochemistry from the University of Illinois Urbana-Champaign and multiple degrees from Stanford University.